JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area tyrosine kinase src'

Search results for: 'research area tyrosine kinase src'

A1845 Canertinib (CI-1033)

Summary: HER family tyrosine kinase inhibitor
A8197 Compound 56

1 Citation

Target: EGFR

Summary: REGFR inhibitor

insoluble in H2O; ≥16.95 mg/mL
A8234 Erlotinib Hydrochloride

2 Citation

Summary: Selective EGFR inhibitor

insoluble in H2O; insoluble in EtOH; ≥6.44 mg/mL
A1367 ALK-IN-1

Summary: Anaplastic lymphoma kinase (ALK) inhibitor

≥26.45 mg/mL
A8218 Lapatinib

2 Citation

Target: ErbB

Summary: EGFR/HER2 inhibitor,potent,selective and reversible

≥29.05 mg/mL
A8219 Gefitinib (ZD1839)

3 Citation

Target: EGFR

Summary: Selective EGFR inhibitor

≥22.34 mg/mL
A5455 AEE788 (NVP-AEE788)

Summary: EGFR/HER-2/VEGFR inhibitor

≥22.05 mg/mL
A8247 Afatinib (BIBW2992)

1 Citation

Target: EGFR

Summary: Irreversible EGFR/HER2 inhibitor

≥24.3 mg/mL
A1835 Pelitinib (EKB-569)

Summary: EGFR inhibitor,potent and irreversible

insoluble in EtOH; insoluble in H2O; ≥11.7 mg/mL
A3794 SB1317

Summary: CDK,JAK and FLT inhibitor

insoluble in H2O; ≥44.87 mg/mL